Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816139 · ClinicalTrials.gov registry record · Phase 3
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
A Phase 3 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 3
- Development phase
- 576
- Enrollment target
NCT01816139 is a Phase 3 study that has completed, run by Warner Chilcott. The registered enrollment target is 576 participants.
The verdict
NCT01816139, a Phase 3 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 576 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the efficacy of WC3011 with placebo vaginal gel in postmenopausal women for the relief of vaginal dryness caused by vaginal atrophy as measured by self-assessment, vaginal pH and vaginal smear.
Interventions
- DRUG Vehicle
- DRUG WC3011 Estradiol Vaginal Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2013-01-31 |
| Est. Completion | 2013-11-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01816139
The ClinicalTrials.gov registry entry for NCT01816139 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 576 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01816139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01816139 about?
NCT01816139 is a clinical study titled "Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women". The primary objective of this study is to compare the efficacy of WC3011 with placebo vaginal gel in postmenopausal women for the relief of vaginal dryness caused by vaginal atrophy as measured by self-assessment, vaginal pH and vaginal smear.
What is the current status of trial NCT01816139?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 576 participants. The study started on 2013-01-31. Estimated completion is 2013-11-19.
What interventions are being tested in trial NCT01816139?
The interventions under investigation include: Vehicle (DRUG), WC3011 Estradiol Vaginal Cream (DRUG).
Who is sponsoring clinical trial NCT01816139?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.